In addition, Li et al., in a preclinical model of prostate cancer, found that BET inhibition’s downregulation of RAD51 and DNA damage repair both enhanced radiation effect and aided in overcoming radioresistance [8]. The gene discussed is RAD51; the disease is prostate carcinoma.